Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics

American Association for the Advancement of Science (AAAS) - Tập 286 Số 5439 - Trang 487-491 - 1999
William E. Evans1, Mary V. Relling1
1Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, USA, and Colleges of Pharmacy and Medicine, University of Tennessee, Memphis, TN 38105, USA.

Tóm tắt

Genetic polymorphisms in drug-metabolizing enzymes, transporters, receptors, and other drug targets have been linked to interindividual differences in the efficacy and toxicity of many medications. Pharmacogenomic studies are rapidly elucidating the inherited nature of these differences in drug disposition and effects, thereby enhancing drug discovery and providing a stronger scientific basis for optimizing drug therapy on the basis of each patient's genetic constitution.

Từ khóa


Tài liệu tham khảo

10.1016/S0140-6736(56)92065-7

10.1126/science.124.3220.484.b

Hughes H. B., Biehl J. P., Jones A. P., Schmidt L. H., Am. Rev. Tuberc. 70, 266 (1954);

10.1136/bmj.2.5197.485

Nebert D. W., Am. J. Hum. Genet. 60, 265 (1997);

10.1146/annurev.pharmtox.37.1.269

10.1038/331442a0

10.1086/301941

10.1007/BF00280101

Poulsen L. et al. 51 289 (1996).

10.1016/S0140-6736(77)91430-1

10.1016/S0027-5107(97)00026-2

10.1007/BF02353477

Nakamura H., et al., J. Pharmacol. Exp. Ther. 274, 1099 (1995);

10.1073/pnas.88.12.5237

10.1097/00008571-199602000-00008

10.1016/0304-3959(93)90229-I

10.1172/JCI113308

10.1016/S0165-6147(00)89065-3

10.1093/jnci/90.16.1225

10.1073/pnas.95.22.13176

10.1002/(SICI)1099-0461(1999)13:3/4<219::AID-JBT13>3.0.CO;2-Z

; E. G. Schuetz W. T. Beck

Schuetz J. D., Mol. Pharmacol. 49, 311 (1996);

10.1002/mc.2940130302

10.1006/scbi.1997.0068

10.1182/blood.V91.5.1749

10.1016/0006-291X(89)91985-2

10.1172/JCI119874

Hancox R. J., Sears M. R., Taylor D. R., Eur. Respir. J. 11, 589 (1999);

; B. J. Lipworth I. P. Hall S. Tan I. Aziz J. C. Crabbe Chest 115 324 (1999);

10.1016/S0009-9236(99)70071-8

F. G. van der Kleij et al. Nephrol. Dial. Transplant. 12 (suppl. 2) 42 (1997);

10.1159/000025845

van der Kleij F. G., et al., Kidney Int. Suppl. 63, S23 (1997) ;

10.1016/S0895-7061(97)00279-3

; L. O'Toole

10.1097/00005344-199812000-00017

10.1097/00004872-199612000-00003

; S. Mizuiri et al. Nephron 75 310 (1997);

10.1172/JCI118270

10.1159/000025605

10.1161/01.HYP.28.6.1081

10.1016/S0140-6736(96)90213-5

Arranz M. et al. 346 281 (1995).

10.1073/pnas.92.26.12260

10.1056/NEJM199801083380203

10.1038/sj.mp.4000249

10.1016/S0006-3223(96)00543-4

10.1016/S0092-8674(00)80728-X

10.1016/0888-7543(92)90042-Q

10.1126/science.275.5301.776

10.1038/nbt1097-954

10.1056/NEJM199907013410106

10.1126/science.281.5384.1820

10.1056/NEJM199802193380803

Pui C. H. Evans W. E. 339 605 (1998).

10.1016/S0140-6736(98)04474-2

10.1097/00008571-199710000-00004

10.1016/S0920-9964(98)00038-3

Caraco Y., Sheller J., Wood A. J., J. Pharmacol. Exp. Ther. 278, 1165 (1996);

10.1097/00008571-199710000-00006

10.1007/BF00637732

10.1056/NEJM198903023200905

10.1038/clpt.1983.242

10.1056/NEJM199006213222502

10.1182/blood.V93.9.2817

10.1016/S0140-6736(98)11079-6

10.7326/0003-4819-129-9-199811010-00007

10.1097/00007691-199810000-00014

10.1016/S0165-6147(96)01007-3

10.1038/clpt.1987.4

10.1161/01.CIR.99.5.674

Donger C. et al. 96 2778 (1997).

Supported in part by grants NIH R37 CA36401 RO1 CA51001 and RO1 CA78224; Cancer Center support grant CA21765; a Center of Excellence grant from the state of Tennessee; and the American Lebanese Syrian Associated Charities (ALSAC). We thank J. Johnson M. Kastan C. Naeve D. Roden E. Schuetz J. Schuetz and E. Tuomanen for helpful suggestions; L. Rawlinson for artistic contributions to Figs. 1 and 3; and S. Davis G. McDugle and F. Munn for help in preparing the manuscript.